Stapedectomy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Stapedectomy is a middle ear surgical procedure in which the entire stapes — the smallest bone in the human body — is removed and replaced with a prosthetic device to restore the conduction of sound vibrations from the eardrum to the inner ear (cochlea). It is performed to treat otosclerosis, a condition in which abnormal bone remodelling immobilises the stapes footplate in the oval window, producing a progressive conductive hearing loss.

The stapes normally rocks back and forth in the oval window membrane like a piston, transmitting sound vibrations from the incus (middle ossicle) into the perilymph fluid of the cochlea. In otosclerosis, abnormal spongy bone (otospongiosis) deposits around the footplate gradually fix it in place, preventing this piston movement. The result is a characteristic low-frequency conductive hearing loss that progresses over years.

Stapedectomy was pioneered by Dr John Shea in 1956 and became the standard surgical treatment for otosclerosis through the 1960s and 1970s. In the total stapedectomy technique, the entire stapes superstructure (crura and head) and the footplate are removed, and the oval window is covered with a tissue graft (typically a vein graft, fat plug, or perichondrium) over which a prosthesis is placed connecting the incus to the graft.

Since the 1980s, stapedectomy has been progressively replaced by stapedotomy — a technically distinct procedure in which only a small fenestration (hole) is created in the footplate while leaving the rest of the footplate and stapes in place. Stapedotomy achieves equivalent or superior hearing outcomes with a lower rate of sensorineural hearing loss. As a result, stapedectomy is now performed mainly as a historical comparator or in specific situations where stapedotomy is technically not feasible (e.g., obliterative otosclerosis with a completely calcified, thick footplate).

The procedure is performed under local anaesthesia with sedation or general anaesthesia through the ear canal using an operating microscope or endoscope, typically taking 45–90 minutes.

Stapedectomy is used primarily to treat otosclerosis and, in selected cases, other forms of stapes fixation causing significant conductive hearing loss.

Otosclerosis (Primary Indication)

Otosclerosis is the most common cause of progressive conductive hearing loss in adults. It affects approximately 0.5–1% of the White European and North American population and is less common in African and Asian populations. The disease is autosomal dominant with approximately 25–40% penetrance, meaning a positive family history is present in roughly 25% of cases. Otosclerosis is bilateral in 70–80% of patients, though the degree of impairment is often asymmetric.

Key audiometric features of otosclerosis include:

• Carhart notch: A characteristic dip at 2 kHz on bone conduction audiometry, caused by the mechanical effect of stapes fixation on the cochlear resonance (not true sensorineural loss)
• Air-bone gap: The difference between air conduction (reduced by stapes fixation) and bone conduction (relatively preserved) thresholds — the gap indicates the degree of conductive loss. Gaps of 30–50 dB are typical in moderate-to-severe otosclerosis.
• Type As (shallow) tympanogram: Reduced compliance due to stapes fixation, with absent acoustic reflexes

Other Stapes Fixation Conditions

• Tympanosclerosis: Calcium deposits (hyalinised, calcified scar tissue) may fix the stapes in the oval window as a complication of chronic otitis media; stapedectomy or stapedotomy can improve hearing if the ossicular chain is otherwise intact
• Congenital stapes fixation: Stapes may be congenitally fused to the oval window; surgical approach requires careful assessment for associated inner ear anomalies (perilymph gusher risk)
• Paget disease of bone: Rarely causes stapes fixation amenable to surgery; generally managed medically with bisphosphonates

Contraindications to Surgery

• Only-hearing ear (single functional ear): the risk of profound post-operative SNHL is unacceptable
• Active outer or middle ear infection
• Poor cochlear reserve (severe pre-existing sensorineural hearing loss reduces expected benefit)
• Professional diver or aviator (inner ear pressure changes increase risk of prosthesis displacement)

Selection for stapedectomy (or the preferred modern stapedotomy) is based on audiometric, clinical, and patient-specific criteria.

Audiometric Criteria

• Air-bone gap: At least 25–30 dB average air-bone gap at 500, 1000, 2000 Hz indicating significant conductive component
• Bone conduction thresholds: Better than 30–35 dB at 500–2000 Hz to ensure cochlear function is sufficient to benefit from restored conduction
• Speech discrimination score: Good speech understanding in the affected ear confirms cochlear reserve and predicts post-operative speech intelligibility improvement
• Absent stapedial reflexes: Confirms stapes fixation

Clinical Criteria

• Dry ear for at least 6–12 weeks (no active infection)
• Intact tympanic membrane
• Normal middle ear anatomy confirmed clinically and if required by high-resolution CT of temporal bones
• CT temporal bones: used to assess footplate thickness, cochlear anomalies, and perilymph gusher risk (particularly in congenital cases)

Patient Factors

• Age: No strict age limit; surgery is safe from adolescence through to the eighth decade if fitness allows. Surgery is generally deferred until hearing loss is functionally significant (prevents useful communication even with hearing aids).
• Pregnancy: Generally deferred until after delivery; otosclerosis may progress in pregnancy due to hormonal influence
• Bilateral disease: The worse-hearing ear is operated first; the second ear (if indicated) at least 6–12 months later, to allow adequate assessment of the first ear outcome
• Patient preference: Motivated patients who understand the risks (including the small but real risk of profound hearing loss) are better surgical candidates

In stapedectomy, the entire stapes is removed and the oval window is bridged with a graft and prosthesis. Understanding the technical differences from stapedotomy (the current preferred technique) helps patients make informed decisions.

Total Stapedectomy — Classical Technique

The procedure is performed under local anaesthesia (with intravenous sedation) or general anaesthesia, through the external ear canal using an operating microscope (transmeatal approach). The steps are:

1. A tympanomeatal flap is elevated, exposing the middle ear
2. The incudostapedial joint is separated, and the stapes superstructure (arch) is fractured and removed
3. The entire stapes footplate is carefully removed in one or multiple pieces using a pick, footplate hook, or laser
4. The oval window is covered with a connective tissue graft — classically a fat plug or vein graft harvested from the earlobe or dorsum of the hand
5. A prosthesis (wire-piston of PTFE, titanium, or stainless steel, 0.4–0.6 mm diameter, 4.5–5.0 mm length) is inserted from the incus long process through the graft into the inner ear
6. The prosthesis wire loop is crimped onto the incus

Stapedectomy vs Stapedotomy — Key Distinction

The critical difference: stapedectomy removes the entire footplate; stapedotomy creates only a small (0.6–1.0 mm) hole in the footplate without removing it. Stapedotomy is the current gold standard because:

• Smaller inner ear opening = less perilymph disturbance and less risk of post-operative sensorineural hearing loss
• Equivalent or better long-term hearing outcomes in multiple comparative studies
• Laser-assisted stapedotomy (CO2 or KTP laser) further reduces trauma and bleeding

Stapedectomy is still performed in cases of obliterative otosclerosis, where extensive calcification of the footplate makes small-fenestration stapedotomy technically impractical.

Prosthesis Types

• Teflon-piston (PTFE): Lightweight, biocompatible, well established; historically the most commonly used
• Titanium prosthesis: Widely used, MRI-compatible (3T), excellent long-term corrosion resistance
• Nitinol (Nitibend) self-crimping prosthesis: Allows temperature-activated secure crimping; reduces risk of loose incus attachment
• Stainless steel wire with fat or gelfoam: Historical designs largely replaced by PTFE and titanium pistons

Stapedectomy (and stapedotomy) offer effective, lasting restoration of hearing in appropriately selected patients with otosclerosis.

Hearing Improvement

• Air-bone gap closure: Complete or near-complete closure of the air-bone gap (to within 10 dB) is achieved in approximately 85–95% of patients undergoing stapedotomy; slightly lower rates with classical stapedectomy in some series
• Pure-tone average improvement: Mean air conduction improvement of 25–35 dB, restoring hearing to socially functional levels in most patients
• Speech discrimination: Significant improvement in speech intelligibility in quiet and noise; patients frequently report they no longer need to ask people to repeat themselves
• Long-term durability: Results are maintained in 80–90% of patients at 10 years; prosthesis displacement or re-fixation by new otosclerotic bone is the primary cause of late failure

Quality of Life

• Elimination of hearing aid dependence in many patients following successful surgery
• Significant improvement in validated health-related quality of life scores, including the Glasgow Benefit Inventory and Hearing Handicap Inventory for Adults
• Improvement in tinnitus: tinnitus is partially or fully relieved in approximately 60–70% of patients post-operatively, though it may worsen in a minority
• Restoration of binaural hearing when both ears are successfully treated

Advantages over Hearing Aids

• Single procedure providing sustained hearing restoration without ongoing maintenance or battery cost
• Natural sound quality without the distortion, feedback, or occlusion effects of hearing aids
• No in-ear device to maintain or replace
• Superior outcomes for bilateral high air-bone gap otosclerosis compared with bilateral amplification

Stapedectomy carries well-characterised risks that every patient must understand before consenting to surgery. The most serious risk is permanent deafness in the operated ear, which — though rare — cannot be reversed.

Sensorineural Hearing Loss (SNHL)

The most feared complication. Entry into the inner ear (either intentional for footplate removal or inadvertent) carries a risk of damaging the delicate cochlear membranes, hair cells, or perilymph circulation. Rates with classical total stapedectomy:

• Mild SNHL (>10 dB at high frequencies): 5–15%
• Severe SNHL (50+ dB loss): 1–3%
• Profound SNHL / total deafness: 0.5–1.5%

These rates are lower with modern stapedotomy (0.5–1% for severe/profound SNHL), which is a primary reason stapedotomy has supplanted stapedectomy as the standard of care.

Perilymph Fistula

Leakage of perilymph fluid from the inner ear through the oval window or through a reparfailure of the graft/seal. Presents as post-operative fluctuating sensorineural hearing loss, vertigo, or tinnitus. Treated with bed rest and avoidance of Valsalva manoeuvres; surgical exploration and re-sealing is required if conservative management fails.

Prosthesis Displacement or Extrusion

The piston may become displaced from the incus or migrate laterally over months to years. Presents as recurrent conductive hearing loss. Requires revision surgery (revision stapedectomy or stapedotomy), which carries higher complication rates than primary surgery due to scarring and altered anatomy.

Facial Nerve Injury

The facial nerve (chorda tympani and occasionally the main trunk) passes through the middle ear. Temporary taste disturbance and altered facial sensation from chorda tympani stretching is common (20–30%). Permanent facial nerve palsy is extremely rare (<0.1%) but serious.

Vertigo

Transient vertigo and disequilibrium are expected in the first 24–48 hours post-operatively due to inner ear manipulation. Persistent vertigo beyond 1–2 weeks may indicate perilymph fistula, labyrinthitis, or prosthesis malposition.

Tympanic Membrane Perforation

The tympanomeatal flap may be torn during elevation or fail to heal, leaving a perforation. This is uncommon (<2%) and usually managed by secondary tympanoplasty if it does not close spontaneously.

Recovery from stapedectomy is generally rapid, though inner ear precautions must be observed for several weeks to protect the healing oval window.

Immediate Post-Operative Period

• Hospital stay: Usually 0–1 days (day surgery or overnight observation)
• Ear packing: The ear canal is packed with gelfoam or a cotton plug; removed at the first post-operative visit (7–14 days)
• Vertigo and disequilibrium: Expected for 24–72 hours; anti-emetics (prochlorperazine or ondansetron) prescribed for nausea
• Activity restrictions: Avoid nose blowing, heavy lifting, straining, diving, contact sports, and flying for 4–6 weeks to protect the oval window graft and prevent perilymph pressure changes
• Water precautions: Keep operated ear dry for 4–6 weeks; shower with cotton wool plug; no swimming until cleared
• Driving: Avoid for 48–72 hours; longer if significant vertigo persists

Hearing Recovery Timeline

• Hearing may initially appear worse or muffled in the first 1–2 weeks due to ear packing and middle ear fluid
• Gradual hearing improvement begins at 2–4 weeks and continues for 3–6 months as oedema resolves and the prosthesis settles
• Formal audiometric assessment at 6–8 weeks provides an early measure of functional outcome; repeat at 3 months and 6 months

Long-Term Follow-Up

• Annual audiometry recommended to monitor for late prosthesis failure, re-fixation, or progression of sensorineural component
• MRI: titanium and PTFE prostheses are MRI-compatible at 1.5T; 3T MRI safety depends on specific prosthesis model — always disclose stapes prosthesis before any MRI scan
• Late revision surgery: recurrent conductive hearing loss (air-bone gap >30 dB after initial closure) at any time post-operatively warrants audiometric assessment and consideration of revision exploration

The cost of stapedectomy or stapedotomy is determined by anaesthetic type, prosthesis selection, laser technology access, surgeon expertise, and hospital setting.

Key Cost Determinants

• Anaesthesia: Local anaesthesia with sedation is significantly less expensive than general anaesthesia and is the preferred approach at most high-volume otology centres
• Laser use: CO2 or KTP laser-assisted stapedotomy adds equipment cost but reduces operating time and potentially complication risk; laser-equipped centres may charge a premium
• Prosthesis type: Titanium and nitinol self-crimping prostheses are more expensive than PTFE-Teflon pistons; the difference per prosthesis ranges from USD 50–500
• Surgeon expertise and volume: High-volume otology subspecialists (50+ stapes procedures per year) command premium fees but deliver demonstrably better outcomes; revision cases require specialist expertise and are priced higher
• Pre-operative audiological assessment: Pure-tone audiometry, tympanometry, speech discrimination testing, and CT temporal bones form part of the diagnostic episode cost

Approximate Regional Pricing

• United States: USD 8,000–20,000 (unilateral, including anaesthesia and facility)
• United Kingdom (private): GBP 3,500–8,000
• India: USD 1,200–4,000 (accredited ENT/otology centres)
• Thailand: USD 2,500–6,000
• Singapore: USD 5,000–12,000
• Turkey: USD 2,000–5,000

Patients travelling abroad for stapedectomy/stapedotomy should ensure the treating surgeon performs at least 50 stapes procedures annually and can provide a post-operative hearing test and remote follow-up plan.

Stapedectomy has been largely superseded by stapedotomy as the preferred surgical option, and non-surgical alternatives exist for patients who decline or cannot undergo surgery.

Stapedotomy (Current Standard of Care)

Stapedotomy creates only a small fenestration (0.6–1.0 mm) in the stapes footplate using a laser (CO2 or KTP) or a hand microdrill, leaving the rest of the footplate intact. A titanium or PTFE piston prosthesis is then inserted through this small hole. Multiple comparative studies and systematic reviews confirm that stapedotomy achieves equivalent or superior hearing outcomes to classical total stapedectomy, with significantly lower rates of post-operative sensorineural hearing loss (severe SNHL 0.5% vs 1–3%) and equivalent long-term durability. Stapedotomy is therefore the recommended first-choice technique for the vast majority of otosclerosis cases, with stapedectomy reserved for obliterative otosclerosis where a small fenestration is not technically feasible.

Conventional Hearing Aids

Air-conduction hearing aids amplify sound to compensate for the air-bone gap. Modern behind-the-ear (BTE) and receiver-in-canal (RIC) digital hearing aids provide excellent amplification for mild-to-moderate conductive hearing loss. Advantages: no surgical risk; reversible; bilateral amplification easily achieved. Disadvantages: device maintenance; battery cost; occlusion effect; in-ear comfort; sound quality inferior to natural hearing restoration; hearing aids do not prevent disease progression. Hearing aids are the first-line management for patients who decline surgery, have poor cochlear reserve, have an only-hearing ear, or are medically unfit for surgery.

Bone-Anchored Hearing Aids (BAHA / Bone Bridge)

Bone conduction devices bypass the middle ear entirely by transmitting vibrations directly through the skull bone to the cochlea. Options range from the non-surgical softband BAHA (worn on a headband) through to the surgically implanted percutaneous BAHA (titanium implant in the mastoid bone) and the Bone Bridge (active implantable transducer). BAHAs are particularly effective for pure conductive hearing loss with good cochlear reserve, and are appropriate for patients who have bilateral obliterative otosclerosis or who are unsuitable for stapes surgery. They require a minor surgical procedure for implantation but carry none of the cochlear risks of stapedectomy/stapedotomy.

Sodium Fluoride Therapy

Sodium fluoride has been advocated as a medical treatment to slow the progression of otosclerosis by stabilising the abnormal bone remodelling process. Evidence for its efficacy in halting conductive hearing loss is weak and inconsistent across trials. Bisphosphonates (used for Paget disease) are similarly of uncertain benefit for cochlear otosclerosis. Neither therapy reverses existing hearing loss. These medical treatments are occasionally used in patients who are not surgical candidates to slow progression, but are not alternatives to surgery for established conductive hearing loss.